Marico Limited Allots 3,856 Equity Shares Under ESOP 2016 Scheme

1 min read     Updated on 24 Mar 2026, 09:26 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Marico Limited allotted 3,856 equity shares under its ESOP 2016 scheme on March 23, 2026, at an exercise price of Rs. 483.50 per share. The allotment increased the company's paid-up share capital from Rs. 1,29,81,45,079 to Rs. 1,29,81,48,935. The newly issued shares will rank pari-passu with existing equity shares and are not subject to any lock-in period. The company has confirmed that this allotment is not material in nature.

powered bylight_fuzz_icon
35870181

*this image is generated using AI for illustrative purposes only.

Marico Limited has announced the allotment of 3,856 equity shares under its Employee Stock Option Plan 2016 (ESOP 2016) scheme on March 23, 2026. The Securities Committee of the Board of Directors approved this allotment through a resolution passed on the same date.

Share Allotment Details

The allotted shares carry specific parameters that define their structure and value:

Parameter Details
Number of Shares 3,856
Face Value Re. 1 each
Exercise Price Rs. 483.50 per share
Premium per Share Rs. 482.50
Issue Date March 23, 2026
Distinctive Numbers 1,29,81,45,080 to 1,29,81,48,935

Impact on Share Capital

The allotment resulted in an increase in Marico's paid-up share capital structure:

Metric Before Allotment After Allotment
Number of Equity Shares 1,29,81,45,079 1,29,81,48,935
Total Share Capital Rs. 1,29,81,45,079 Rs. 1,29,81,48,935

Regulatory Compliance

The allotment was conducted in accordance with the Marico Employee Stock Option Plan 2016, with shares issued to eligible grantees pursuant to the exercise of stock options. The company has fulfilled disclosure requirements under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Share Characteristics

The newly allotted equity shares will rank pari-passu with existing equity shares of the company, ensuring identical rights and privileges. No lock-in period applies to these shares, and they are issued in demat form under ISIN number INE196A01026. Marico has clarified that this allotment is not material in nature to the company's operations.

The company's shares are listed on both BSE Limited and the National Stock Exchange of India Limited, and the allotment information has been made available on Marico's investor relations website.

Historical Stock Returns for Marico

1 Day5 Days1 Month6 Months1 Year5 Years
+0.08%-1.15%-5.52%+6.18%+15.06%+82.96%

How might this ESOP allotment impact employee retention and talent acquisition strategies at Marico in the coming quarters?

What does the exercise price of Rs. 483.50 suggest about employee confidence in Marico's future stock performance compared to current market levels?

Could this small-scale ESOP exercise indicate a broader trend of employee stock option exercises across Marico's workforce in 2026?

Nuvama Maintains Buy Rating on Marico with ₹900 Target Price Amid Strong VAHO Growth

1 min read     Updated on 17 Mar 2026, 09:17 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Nuvama Securities maintains Buy rating on Marico with ₹900 target price, citing strong VAHO growth of 29% in Q3FY26 and stable Bangladesh operations. The company benefits from limited Middle East exposure (3-4%) and potential price cuts from ~35% copra correction, while monitoring regional tensions for cost inflation risks.

powered bylight_fuzz_icon
35264869

*this image is generated using AI for illustrative purposes only.

Marico has received a maintained Buy rating from Nuvama Securities with a target price of ₹900, supported by strong operational performance and strategic positioning across key markets.

Strong VAHO Performance Drives Growth

The company demonstrated robust growth in its Value Added Hair Oil (VAHO) segment, recording impressive growth of 29% in Q3FY26. This strong performance in the premium hair care category reflects Marico's successful product positioning and market penetration strategies.

Regional Operations and Market Exposure

Parameter: Details
Bangladesh Operations: Stable momentum maintained
Middle East Revenue Exposure: Limited to 3-4%
VAHO Growth (Q3FY26): 29%
Copra Price Correction: ~35% decline

Marico's Bangladesh operations continue to show stable momentum, providing consistent contribution to the company's international business. The limited Middle East revenue exposure of 3-4% offers some protection against regional geopolitical uncertainties.

Cost Structure and Pricing Strategy

Nuvama highlighted the potential benefits from a significant ~35% correction in copra prices, which represents a key raw material for the company's coconut oil-based products. This substantial cost reduction could enable Marico to implement strategic price cuts, potentially boosting volume growth and market share expansion.

Risk Monitoring and Market Outlook

While maintaining its positive outlook, Nuvama continues to monitor Middle East tensions for possible impacts on raw material and packaging cost inflation. The brokerage's cautious approach reflects awareness of potential supply chain disruptions and cost pressures that could emerge from regional instability.

The maintained Buy rating with ₹900 target price reflects Nuvama's confidence in Marico's operational execution and strategic positioning across its key markets, balanced against ongoing monitoring of external risk factors.

Historical Stock Returns for Marico

1 Day5 Days1 Month6 Months1 Year5 Years
+0.08%-1.15%-5.52%+6.18%+15.06%+82.96%

More News on Marico

1 Year Returns:+15.06%